The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Proline Residues in Human Immunodeficiency Virus Type 1 p6 Gag Exert a Cell Type-Dependent Effect on Viral Replication and Virion Incorporation of Pol Proteins
Open accessAbstract
The C terminus of the HIV-1 Gag protein contains a proline-rich domain termed p6(Gag). This domain has been shown to play a role in efficient virus release and incorporation of Vpr into virions. In a previous study (X. F. Yu, L. Dawson, C. J. Tian, C. Flexner, and M. Dettenhofer, J. Virol. 72:3412-3417, 1998), we observed that the removal of the p6 domain of Gag as well as drastic mutations in the PTAP motif resulted in reduced virion-associated Pol proteins from transfected COS cells. In the present study, amino acid substitutions at residues 5 and 7 of p6(Gag) resulted in a cell type-dependent replication of the mutant virus in CD4(+) T cells; the virus was replication competent in Jurkat cells but restricted in H9 cells and primary blood-derived monocytes. Established Jurkat and H9 cell lines expressing p6(Gag) mutant and parental virus were used to further understand this defect. Mutant virions produced from H9 cells, which displayed no defect in extracellular virion production, showed an approximately 16-fold reduction in Pol protein levels, whereas the levels of Pol proteins were only marginally reduced in mutant virions produced from Jurkat cells. The reduction in the virion-associated Pol proteins could not be accounted for by differences in the levels of intracellular p160(Gag-Pol) or in the interaction between p55(Gag) and p160(Gag-Pol) precursors. Electron microscopic analysis of the p6(Gag) mutant virions showed a predominately immature morphology in the absence of significant defects in Gag proteolytic cleavage. Taken together, these data suggest that the proline-rich motif of p6(Gag) is involved in the late stages of virus maturation, which include the packaging of cleaved Pol proteins in viral particles, a process which may involve cell-type-specific factors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It has been known for over two decades that the L domains encoded by the retroviral Gag polyprotein are critical for the proper packaging of the essential viral processing enzymes required for maturation and infectivity, known as the Gag-Pol polyprotein [43,44,45].”
From Budding of a Retrovirus: Some Assemblies Required (2020) · cites this paper as [43]
Citations
Cites
Göttlinger, H. G., Sodroski, J. G., & Haseltine, W. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5781 · Cited by 841
Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein
Gamble, T. R., Yoo, S., Vajdos, F. F., von Schwedler, U. K., Worthylake, D. K., Wang, H., McCutcheon, J. P., Sundquist, W. I., & Hill, C. P. (1997) · Science · doi:10.1126/science.278.5339.849 · Cited by 598
Hill, C. P., Worthylake, D., Bancroft, D. P., Christensen, A. M., & Sundquist, W. I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.3099 · Cited by 473
Dorfman, T., Mammano, F., Haseltine, W. A., & Göttlinger, H. G. (1994) · Journal of Virology · doi:10.1128/jvi.68.3.1689-1696.1994 · Cited by 288 · cited 1×
“MA also plays another role during virus assembly, that of incorporating the viral envelope glycoproteins into the surfaces of virions (9, 12, 40) by interacting with the cytoplasmic tail of gp41 (6, 10, 12, 41).”
BackgroundParent, L. J., Bennett, R. P., Craven, R. C., Nelle, T. D., Krishna, N. K., Bowzard, J. B., Wilson, C. B., Puffer, B. A., Montelaro, R. C., & Wills, J. W. (1995) · Journal of Virology · doi:10.1128/jvi.69.9.5455-5460.1995 · Cited by 258 · cited 2×
“Motifs of the L domains in HIV-1 p6 (PTAPP), equine infectious anemia virus p9 (YXXL), and Rous sarcoma virus p2 (PPPPY) have been shown to be functionally interchangeable with regard to their effects on particle release (30).”
BackgroundPuffer, B. A., Parent, L. J., Wills, J. W., & Montelaro, R. C. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6541-6546.1997 · Cited by 217
Research works printed but not linked: 41
- Ansari-Lari M. A. Donehower L. A. Gibbs R. A. Analysis of human immunodeficiency virus type 1 integrase mutants.Virology 213 1995 680
- 10.1128/jvi.70.6.3870-3875.1996 · DOI
- 10.1128/jvi.67.11.6487-6498.1993 · DOI
- 10.1128/JVI.72.11.9034-9044.1998 · DOI
- 10.1073/pnas.87.2.523 · DOI
- 10.1002/j.1460-2075.1996.tb00964.x · DOI · Paper page
- 10.1128/jvi.69.7.4213-4227.1995 · DOI
- 10.1006/viro.1998.9374 · DOI · Paper page
- 10.1128/jvi.66.11.6616-6625.1992 · DOI
- 10.1128/jvi.69.5.2729-2736.1995 · DOI · Paper page
- 10.1128/jvi.68.8.5300-5305.1994 · DOI
- 10.1128/jvi.70.1.341-351.1996 · DOI
- 10.1038/350508a0 · DOI
- 10.1128/JVI.72.6.4667-4677.1998 · DOI
- 10.1038/381744a0 · DOI
- 10.1073/pnas.88.8.3195 · DOI · Paper page
- 10.1128/jvi.69.11.6810-6818.1995 · DOI · Paper page
- 10.1128/jvi.71.6.4472-4478.1997 · DOI
- 10.1128/JVI.72.3.2047-2054.1998 · DOI
- 10.1128/jvi.69.5.2759-2764.1995 · DOI
- 10.1128/jvi.65.1.162-169.1991 · DOI
- 10.1128/jvi.69.11.6873-6879.1995 · DOI
- 10.1006/jmbi.1996.0742 · DOI
- 10.1128/jvi.68.8.4927-4936.1994 · DOI · Paper page
- 10.1128/JVI.72.9.7659-7663.1998 · DOI
- 10.1128/jvi.70.6.3440-3448.1996 · DOI
- 10.1128/jvi.67.12.7229-7237.1993 · DOI
- 10.1038/313277a0 · DOI
- 10.1128/JVI.72.4.2723-2732.1998 · DOI
- 10.1006/viro.1996.0532 · DOI
- 10.1128/jvi.69.10.6106-6114.1995 · DOI
- 10.1128/jvi.66.12.7021-7032.1992 · DOI
- Swanstrom R. Wills J. Synthesis assembly and processing of viral proteins Retroviruses. Coffin J. Hughes S. Varmus H. 1998 263 334 Cold Spring Harbor Laboratory Press Cold Spring Harbor N.Y
- 10.1128/JVI.72.5.4095-4103.1998 · DOI
- 10.1128/jvi.66.8.4966-4971.1992 · DOI
- 10.1128/jvi.67.1.213-221.1993 · DOI
- 10.1128/JVI.72.4.3412-3417.1998 · DOI · Paper page
- 10.1099/0022-1317-76-12-3171 · DOI
- 10.1128/jvi.67.11.6387-6394.1993 · DOI
- 10.1128/JVI.72.3.1782-1789.1998 · DOI
- 10.1128/jvi.68.4.2556-2569.1994 · DOI
Cited by
Sorted by citations
Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55 Gag
VerPlank, L., Bouamr, F., LaGrassa, T. J., Agresta, B., Kikonyogo, A., Leis, J., & Carter, C. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131059198 · Cited by 584
Freed, E. O. (2002) · Journal of Virology · doi:10.1128/jvi.76.10.4679-4687.2002 · Cited by 423
Demirov, D. G., Orenstein, J. M., & Freed, E. O. (2002) · Journal of Virology · doi:10.1128/jvi.76.1.105-117.2002 · Cited by 201
“A similar effect of p6 mutation on the levels of pol products in virions has been observed previously (6, 65, 66).”
BackgroundCell Biology of HIV-1 Infection of Macrophages
Carter, C. A., & Ehrlich, L. S. (2008) · Annual Review of Microbiology · doi:10.1146/annurev.micro.62.081307.162758 · Cited by 188
Maguire, M. F., Guinea, R., Griffin, P., Macmanus, S., Elston, R., Wolfram, J., Richards, N., Hanlon, M., Porter, D. J. T., Wrin, T., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.15.7398-7406.2002 · Cited by 164
Ubiquitination of HIV-1 and MuLV Gag
Ott, D. E., Coren, L. V., Chertova, E. N., Gagliardi, T. D., & Schubert, U. (2000) · Virology · doi:10.1006/viro.2000.0648 · Cited by 146
Peters, S., Muñoz, M., Yerly, S., Sánchez-Merino, V., López‐Galíndez, C., Perrin, L. H., Larder, B. A., Cmarko, D., Fakan, S., Meylan, P. R., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.20.9644-9653.2001 · Cited by 76
Ebola Virus VP40 Late Domains Are Not Essential for Viral Replication in Cell Culture
Neumann, G., Ebihara, H., Takada, A., Noda, T., Kobasa, D., Jasenosky, L. D., Watanabe, S., Kim, J. H., Feldmann, H., & Kawaoka, Y. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10300-10307.2005 · Cited by 85
“the P(T/S)AP motif have an early effect on budding (5).”
BackgroundClinical Significance of Human Immunodeficiency Virus Type 1 Replication Fitness
Dykes, C., & Demeter, L. M. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00017-07 · Cited by 76
“Similarly, K65R and M184V also have antagonistic effects on fitness that are associated with abnormalities in nucleotide incorporation (46).”
BackgroundMethodInfluentialHemonnot, B., Cartier, C., Gay, B., Rebuffat, S. A., Bardy, M., Devaux, C. A., Boyer, V., & Briant, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313137200 · Cited by 79
Sequences within Pr160gag-pol affecting the selective packaging of primer tRNA(Lys3) into HIV-1.
Khorchid, A., Javanbakht, H., Wise, S., Halwani, R., Parniak, M., Wainberg, M., & Kleiman, L. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3709 · Cited by 69
A Bipartite Late-Budding Domain in Human Immunodeficiency Virus Type 1
Martin‐Serrano, J., & Bieniasz, P. D. (2003) · Journal of Virology · doi:10.1128/jvi.77.22.12373-12377.2003 · Cited by 57
Müller, B., Patschinsky, T., & Kräusslich, H. (2002) · Journal of Virology · doi:10.1128/jvi.76.3.1015-1024.2002 · Cited by 61
HIV-1 Protease and Reverse Transcriptase Control the Architecture of Their Nucleocapsid Partner
Mirambeau, G., Lyonnais, S., Coulaud, D., Hameau, L., Lafosse, S., Jeusset, J., Borde, I., Reboud-Ravaux, M., Restle, T., Gorelick, R., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000669 · Cited by 53
“p6 domains directly favour the retention of the Gag-Pol protein within the immature capsid [39].”
BackgroundKaufmann, G. R., Suzuki, K., Cunningham, P., Mukaide, M., Kondo, M., Imai, M., Zaunders, J., & Cooper, D. A. (2001) · AIDS Research and Human Retroviruses · doi:10.1089/08892220151126526 · Cited by 46
“19 Changes in this domain may reduce viral fitness and increase the efficacy of antiretroviral therapy.”
InfluentialCen, S., Niu, M., Saadatmand, J., Guo, F., Huang, Y., Nabel, G. J., & Kleiman, L. (2003) · Journal of Virology · doi:10.1128/jvi.78.2.1042-1049.2004 · Cited by 31
“Thus, previous reports have presented data that suggest that the HIV-1 Gag p6 domain functions to retain the Pol domain proteins within the assembling virus after the initial activation of the viral PR (11, 55).”
BackgroundInduced Maturation of Human Immunodeficiency Virus
Mattei, S., Anders, M., Konvalinka, J., Kräusslich, H.-G., Briggs, J. A. G., & Müller, B. (2014) · Journal of Virology · doi:10.1128/jvi.02271-14 · Cited by 42
“purification was performed between the two pelleting steps by centrifugation through an iodixanol density gradient as described previously (32).”
MethodPaulus, C., Ludwig, C., & Wagner, R. (2004) · Virology · doi:10.1016/j.virol.2004.09.013 · Cited by 27
“The observation that the M1 mutant proved to be absolutely noninfectious in different cell culture systems is concurrent with former findings, that packaging of Gag-Pol polyproteins containing the essential enzymatic activities of RT, PR and IN strongly correlates with the infectivity of the corresponding virions (Det…”
ResultAnalysis of Insertions and Deletions in the gag p6 Region of Diverse HIV Type 1 Strains
Marlowe, N., Flys, T. S., Hackett, J., Schumaker, M., Jackson, J., & Eshleman, S. (2004) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2004.20.1119 · Cited by 33
Budding of a Retrovirus: Some Assemblies Required
Rose, K. M., Hirsch, V. M., & Bouamr, F. (2020) · Viruses · doi:10.3390/v12101188 · Cited by 32
How HIV-1 Gag Manipulates Its Host Cell Proteins: A Focus on Interactors of the Nucleocapsid Domain
Klingler, J., Anton, H., Réal, É., Zeiger, M., Moog, C., Mély, Y., & Boutant, E. (2020) · Viruses · doi:10.3390/v12080888 · Cited by 41
“The 36YPLTSL sequence plays a role for the incorporation of Env [72] and the proline rich C-terminal region of p6 drives the packaging of cleaved Pol proteins [198,199].”
BackgroundAspects of HIV-1 assembly that promote primer tRNALys3 annealing to viral RNA
Saadatmand, J., & Kleiman, L. (2012) · Virus Research · doi:10.1016/j.virusres.2012.06.001 · Cited by 26
PTAP motif duplication in the p6 Gag protein confers a replication advantage on HIV-1 subtype C
Sharma, S., Arunachalam, P. S., Menon, M. R., Ragupathy, V., Satya, R. V., Jebaraj, J., Aralaguppe, S. G., Rao, C., Pal, S., Saravanan, S., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.815829 · Cited by 17
“Advantages due to an additional PTAP motif might be celltype–dependent, as demonstrated previously (30, 65).”
MethodBrumme, Z., Chan, K., Dong, W., Wynhoven, B., Mo, T., Hogg, R., Montaner, J., O'Shaughnessy, M., & Harrigan, P. (2002) · Antiviral Therapy · doi:10.1177/135965350300800202 · Cited by 17
“The interaction of HIV p6 with Tsg-101 is believed to be required for the release of new infectious viral particles from the host cell surface [8,9], in a cell typedependent manner [4,5].”
BackgroundReichert, M., Winnicka, A., Willems, L., Kettmann, R., & Cantor, G. (2001) · Journal of Virology · doi:10.1128/jvi.75.17.8082-8089.2001 · Cited by 17
“In human immunodeficiency virus type 1 (HIV-1) and other retroviruses, proline-rich motifs are essential in a variety of late processes in the viral life cycle, including efficient release of particles from the cell surface (14), viral maturation (10), and incorporation of the Pol proteins, reverse transcriptase (RT)…”
BackgroundBleiber, G., Peters, S., Martínez, R., Cmarko, D., Meylan, P., & Telenti, A. (2004) · Journal of General Virology · doi:10.1099/vir.0.19576-0 · Cited by 16
“…has shown that truncation of p6 at various positions or specific amino acid changes alter virus production and propagation significantly (Göttlinger et al., 1991; Huang et al., 1995; Yu et al., 1995, 1998; Garnier et al., 1998; Dettenhofer & Yu, 1999; Ott et al., 1999; Peters et al., 2001).”
BackgroundRobinson, L., Gale, C. V., & Kleim, J. (2002) · Journal of Virological Methods · doi:10.1016/s0166-0934(02)00059-9 · Cited by 16
Whitehurst, N., Chappey, C., Petropoulos, C. J., Parkin, N., & Gamarnik, A. (2003) · AIDS Research and Human Retroviruses · doi:10.1089/088922203769232575 · Cited by 15
Hill, M. K., Bellamy-McIntyre, A. K., Vella, L. J., Campbell, S. M., Marshall, J., Tachedjian, G., & Mak, J. (2006) · Current HIV Research · doi:10.2174/157016207779316323 · Cited by 21
“has a role in the packaging of the mature Pol proteins [7, 11 , 46].”
BackgroundWang, S., Sotcheff, S. L., Gallardo, C. M., Jaworski, E. A., Torbett, B. E., & Routh, A. L. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab1259 · Cited by 7
“Replacing the P453 and P455 showed reduced viral replication in primary monocytes (56), which might account for the consistent low frequency of P453S in viral strains we analyzed.”
BackgroundOjesina, A., Chaplin, B., Sankalé, J., Murphy, R., Idigbe, E., Adewole, I., Ekong, E., Idoko, J., & Kanki, P. (2008) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2007.0308 · Cited by 9
Adamson, C. S., Davies, A., Soneoka, Y., Nermut, M., Mitrophanous, K., & Jones, I. (2003) · Virology · doi:10.1016/s0042-6822(03)00485-9 · Cited by 7
Nikolaitchik, O. A., Gorelick, R. J., Leavitt, M. G., Pathak, V. K., & Hu, W.-S. (2008) · Virology · doi:10.1016/j.virol.2008.02.026 · Cited by 5
“The PTAP* mutants have been shown to have lower RT activity (Dettenhofer and Yu, 1999;Yu et al., 1998), which could have caused the differences.”
BackgroundWang, J.-J., Sandefur, S., Spearman, P., Ou, C.-C. T., Chiang, P., & Ratner, L. (2001) · Applied immunohistochemistry & molecular morphology (Print) · doi:10.1097/00129039-200112000-00014 · Cited by 6
Qi, H., Zhao, K., Xu, F., Zhang, X.-Z., Zhang, Z.-Y., Yang, L., Li, C.-L., Liang, X., Guo, W.-G., Chen, S.-H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068656 · Cited by 5
“The p6 region of HIV-1 Gag is involved in virus release [24], viral maturation [25], and Pol protein retention [26,27].”
BackgroundSelf-citationGuan, Y., Diallo, K., Detorio, M., Whitney, J., Liang, C., & Wainberg, M. (2001) · Journal of Virology · doi:10.1128/jvi.75.23.11920-11923.2001 · Cited by 5
“Of course, the p6 protein is also important in the incorporation of viral proteins into virions and is involved in encapsidation of viral RNA (1, 9 , 22).”
BackgroundTargeting Human Immunodeficiency Virus Type 1 Assembly, Maturation and Budding
Wapling, J., Srivastava, S., Shehu-Xhilaga, M., & Tachedjian, G. (2007) · Drug Target Insights · doi:10.1177/117739280700200020 · Cited by 11
“The proline rich region of p6 has also been implicated in the packaging of cleaved Pol proteins into virions, which is suggested to be mediated by host cell proteins (Dettenhofer and Yu, 1999; Cen et al. 2004).”
Identifying Conserved Regions in HIV-1 Proteins by Entropy Analysis of Sequence Variability
Shchemelev, A. N., Николаевна, С. Е., Ostankova, Y. V., Davydenko, V. S., Ramsay, E. S., & Тотолян, А. А. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27115139
Lysova, I., Didier, P., Messaddeq, N., Bouthenet, J., Mély, Y., & Anton, H. (2026) · Methods and Applications in Fluorescence · doi:10.1088/2050-6120/ae5504
“This domain is also crucial for packaging of several viral proteins [16–18] and vRNA [19].”
Jason, U. B., & Anand, D. A. (2014) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/1343
Metadata
- Authors
- Dettenhofer, M., & Yu, X.-F.
- Affiliations
- Johns Hopkins University (US)
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 1999-06
- Volume
- 73
- Issue
- 6
- Pages
- 4696-4704
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC112511
- OpenAlex
- W2147833851
- Cited by
- 44
- References
- 0
- Citations by year
- 2026: 1 · 2022: 1 · 2021: 1 · 2020: 2 · 2018: 1 · 2014: 3 · 2013: 1 · 2012: 1
- FWCI
- 1.56
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Virology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r29ai035525-04)
- National Institute of Allergy and Infectious Diseases (AI-35525)
- National Institute of Environmental Health Sciences (ES 07141, T32ES007141)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Keywords
- proline-rich region, PTAP motif, viral replication, cell type dependence, viral assembly, virus maturation, CD4+ T cells, Jurkat cells, H9 cells, monocytes, virion morphology
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Microscopy, Electron, Molecular Sequence Data, Proline, Protein Precursors, Structure-Activity Relationship, Virion, Virus Replication, HIV-1, Gene Products, gag, Gene Products, pol, Fusion Proteins, gag-pol, Virus Assembly, COS Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review